Targeted Maytansinoid Conjugate Improves Therapeutic Index for Metastatic Breast Cancer Cells.

Volume: 29, Issue: 9, Pages: 2920 - 2926
Published: Aug 13, 2018
Abstract
This study was undertaken to target cell surface receptors other than the ones typically associated with breast cancer {estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2)}. It was also launched to use small molecules other than those most widely used for active targeting in general ( e.g. folate and carbonic anhydrase IX ligands). Specifically, the focus of this study was on unique small...
Paper Details
Title
Targeted Maytansinoid Conjugate Improves Therapeutic Index for Metastatic Breast Cancer Cells.
Published Date
Aug 13, 2018
Volume
29
Issue
9
Pages
2920 - 2926
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.